Ligand Pharma (LGND)

Ligand Pharma (LGND) Financial Statements


Ligand Pharma Financial Overview

Ligand Pharma's market cap is currently ―. The company's EPS TTM is $1.451; its P/E ratio is 41.48; Ligand Pharma is scheduled to report earnings on November 7, 2023, and the estimated EPS forecast is $0.59. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 26.37M$ 17.15M$ 27.05M$ 66.09M$ 57.42M
Gross Profit$ 24.70M$ 40.26M$ 5.43M$ 51.94M$ 45.06M
EBIT$ 3.46M$ 54.34M$ 55.15M$ 1.19M$ -198.00K
EBITDA$ 12.20M$ 62.88M$ 53.93M$ 14.69M$ 12.89M
Net Income Common Stockholders$ 2.29M$ 43.61M$ 10.66M$ 404.00K$ -895.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 219.04M$ 282.67M$ 211.87M$ 121.41M$ 147.94M
Total Assets$ 758.11M$ 811.08M$ 762.67M$ 1.05B$ 1.08B
Total Debt$ 11.67M$ 88.68M$ 87.75M$ 113.89M$ 144.61M
Net Debt$ -207.37M$ -193.99M$ -124.12M$ -7.52M$ -3.32M
Total Liabilities$ 93.21M$ 164.76M$ 165.18M$ 234.31M$ 273.92M
Stockholders Equity$ 664.89M$ 646.32M$ 597.49M$ 816.30M$ 802.37M
Cash Flow-
Free Cash Flow$ -285.00K$ 31.53M$ 51.34M$ 15.20M$ 5.29M
Operating Cash Flow$ -82.00K$ 33.95M$ 53.47M$ 20.49M$ 11.88M
Investing Cash Flow$ 7.56M$ 10.55M$ -7.28M$ 19.18M$ 37.85M
Financing Cash Flow$ -67.76M$ -775.00K$ -5.30M$ -40.83M$ -59.44M
Currency in USD

Ligand Pharma Earnings and Revenue History

Ligand Pharma Debt to Assets

Ligand Pharma Cash Flow

Ligand Pharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis